Inventor · disambiguated record
Chao Lin
Also filed as: LIN CHAO · LIN CHAO-YAN
18 granted patents·9 pending applications·240 citations·filing 1996–2023
94Inventor score
Top patents by PatentIndex Score
27 records- 0196US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0295US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 0394US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 0494US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 0592US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 0683US7494660B2HCV NS3-NS4A protease resistance mutantsVERTEX PHARMA·Filed 2004·Granted Feb 24, 2009·21 cites·23 claims
- 0782US12077784B2Suspension system for adeno associated virus productionLIFE TECHNOLOGIES CORP·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0881US7705138B2Hepatitis C virus variantsVERTEX PHARMA·Filed 2006·Granted Apr 27, 2010·5 cites·28 claims
- 0980US6183121B1Hepatitis C virus helicase crystals and coordinates that define helicase binding pocketsVERTEX PHARMA·Filed 1998·Granted Feb 6, 2001·61 cites·17 claims
- 1074US7884199B2HCV NS3-NS4 protease resistance mutantsVERTEX PHARMA·Filed 2008·Granted Feb 8, 2011·2 cites·24 claims
- 1168US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 1267US8258116B2Combination therapy for the treatment of HCV infectionKWONG ANN·Filed 2008·Granted Sep 4, 2012·1 cites·15 claims
- 1364US6153579ACrystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complexVERTEX PHARMA·Filed 1996·Granted Nov 28, 2000·26 cites·9 claims
- 1459US7438920B1Crystals of hepatitis C virus helicase or fragments thereof comprising a helicase binding pocketVERTEX PHARMA·Filed 1999·Granted Oct 21, 2008·21 cites·3 claims
- 1556US11256966B2Smart medication identifying systemUNIV SOUTHERN TAIWAN SCI & TEC·Filed 2019·Granted Feb 22, 2022·1 cites·5 claims
- 1656US6303287B1Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complexVERTEX PHARMA·Filed 1999·Granted Oct 16, 2001·19 cites·8 claims
- 1755US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 1855US2013344476A1Hepatitis c virus variantsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1954US2014199684A1Methods for amplifying hepatitis c virus nucleic acidsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2053US2011059886A1HCV NS3-NS4A Protease InhibitionVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 2152US2002042046A1Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complexVERTEX PHARMA·Filed 2001·Application pending·0 cites
- 2249US8501450B2Hepatitis C virus variantsLIN CHAO·Filed 2010·Granted Aug 6, 2013·0 cites·13 claims
- 2349US2008267915A1Hcv Ns3-Ns4a Protease InhibitionVERTEX PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 2447US2002187488A1Quantitative assay for nucleic acidsFiled 2002·Application pending·0 cites
- 2546US2011086006A1HCV NS3-NS4 Protease Resistance MutantsVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 2643US2012295843A1Combination therapy for the treatment of hcv infectionKWONG ANN·Filed 2012·Application pending·0 cites
- 2741US8679740B2Methods for amplifying hepatitis C virus nucleic acidsKWONG ANN DAK-YEE·Filed 2011·Granted Mar 25, 2014·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Chao Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →